Machina Capital S.A.S. Purchases New Holdings in Encompass Health Corporation $EHC

Machina Capital S.A.S. purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC) in the 2nd quarter, Holdings Channel reports. The fund purchased 3,385 shares of the company’s stock, valued at approximately $415,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. WPG Advisers LLC bought a new stake in Encompass Health in the first quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Encompass Health by 749.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after buying an additional 367 shares during the period. Park Place Capital Corp bought a new stake in Encompass Health in the second quarter valued at approximately $72,000. Caitong International Asset Management Co. Ltd raised its stake in Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after buying an additional 115 shares during the period. Finally, SVB Wealth LLC bought a new stake in Encompass Health in the first quarter valued at approximately $84,000. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the topic of several research analyst reports. Truist Financial upped their price objective on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. Zacks Research upgraded Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Barclays increased their target price on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. UBS Group increased their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, October 2nd. Finally, Bank of America increased their target price on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Three analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company. According to data from MarketBeat, Encompass Health currently has an average rating of “Buy” and an average target price of $142.86.

Insider Activity

In other news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.00% of the company’s stock.

Encompass Health Trading Up 0.9%

Shares of EHC opened at $117.17 on Wednesday. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.99. The business’s fifty day moving average is $124.00 and its 200-day moving average is $119.29. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market cap of $11.80 billion, a price-to-earnings ratio of 22.15, a PEG ratio of 2.20 and a beta of 0.93.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The company had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.